Canada Life
CPRX

Canada Life’s Catalyst Pharmaceutical CPRX Stock Holding History

Canada Life’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.1M Buy
98,671
+3,357
+4% +$99.1K ﹤0.01% 1006
2026
Q1 		$2.36M Sell
95,314
-3,267
-3% -$77.8K ﹤0.01% 1093
2025
Q4 		$2.3M Sell
98,581
-31,442
-24% -$700K ﹤0.01% 1112
2025
Q3 		$2.54M Buy
130,023
+2,323
+2% +$47.8K ﹤0.01% 1129
2025
Q2 		$2.77M Buy
127,700
+5,677
+5% +$134K ﹤0.01% 1053
2025
Q1 		$2.96M Sell
122,023
-11,184
-8% -$252K 0.01% 1030
2024
Q4 		$2.78M Sell
133,207
-4,007
-3% -$86.1K ﹤0.01% 1117
2024
Q3 		$2.73M Sell
137,214
-3,725
-3% -$69.1K ﹤0.01% 1165
2024
Q2 		$2.18M Sell
140,939
-6,306
-4% -$98.2K ﹤0.01% 1250
2024
Q1 		$2.35M Buy
147,245
+16,599
+13% +$250K ﹤0.01% 1166
2023
Q4 		$2.19M Sell
130,646
-8,488
-6% -$116K ﹤0.01% 1208
2023
Q3 		$1.62M Buy
139,134
+8,348
+6% +$112K ﹤0.01% 1312
2023
Q2 		$1.76M Sell
130,786
-4,327
-3% -$62.3K ﹤0.01% 1265
2023
Q1 		$2.24M Sell
135,113
-9,531
-7% -$157K 0.01% 1173
2022
Q4 		$2.69M Buy
144,644
+21,671
+18% +$334K 0.01% 1071
2022
Q3 		$1.57M Buy
122,973
+117,547
+2,166% +$1.39M ﹤0.01% 1289
2022
Q2 		$38K Hold
5,426
– – ﹤0.01% 2109
2022
Q1 		$48K Hold
5,426
– – ﹤0.01% 2168
2021
Q4 		$37K Hold
5,426
– – ﹤0.01% 2252
2021
Q3 		$29K Hold
5,426
– – ﹤0.01% 2363
2021
Q2 		$31K Hold
5,426
– – ﹤0.01% 2394
2021
Q1 		$25K Hold
5,426
– – ﹤0.01% 2473
2020
Q4 		$18K Hold
5,426
– – ﹤0.01% 2556
2020
Q3 		$16K Hold
5,426
– – ﹤0.01% 2478
2020
Q2 		$25K Hold
5,426
– – ﹤0.01% 2438
2020
Q1 		$21K Hold
5,426
– – ﹤0.01% 2357
2019
Q4 		$20K Buy
+5,426
New +$25.4K ﹤0.01% 2494
2019
Q3 		– Sell
-10,227
Closed -$39K – 1376
2019
Q2 		$39K Buy
+10,227
New +$44.2K ﹤0.01% 2500

Other funds holding CPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Canada Life's CPRX Position: Q2 2026 in Review

Canada Life increased its Catalyst Pharmaceutical (CPRX) stake by 3.5% in Q2 2026, buying an estimated $99.1K and bringing the position to 98,671 shares worth $3.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1006.

Canada Life first reported a position in CPRX in Q2 2019 and has held it in 28 quarters since. 395 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • Canada Life held 98,671 shares of Catalyst Pharmaceutical worth $3.1M as of Q2 2026.
  • Canada Life bought 3,357 Catalyst Pharmaceutical shares in Q2 2026, an estimated $99.1K.
  • Catalyst Pharmaceutical made up ﹤0.01% of Canada Life's portfolio in Q2 2026, its #1006 holding.
  • Canada Life first reported a position in Catalyst Pharmaceutical in Q2 2019 and has held it in 28 quarters since.
  • 395 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Canada Life's 13F filing for Q2 2026, filed 13 Aug 2026.